A Study of the Plasmodium Falciparum Malaria Vaccine Candidate Pfs48/45 in Matrix-M Adjuvant in the UK
Clinical trial NCT05400746 · TERMINATED
Trial details
- NCT number
- NCT05400746
- Sponsor
- University of Oxford
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-02
- Primary completion
- 2023-10-19
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.